3D Medical Imaging Market size was valued at US$ 29.65Bn. in 2021 and the total 3D Medical Imaging revenue is expected to grow at 6.7% through 2022 to 2029, reaching nearly US$ 49.81 Bn.3D Medical Imaging Market Overview:
Due to its widespread applicability in practically all patient-related management, medical imaging is at the heart of the healthcare sector. The use of computed tomography, magnetic resonance imaging (MRI), and other medical imaging modalities has improved health practitioners' ability to identify and treat patients' diseases. These modalities are fast evolving, moving from black-and-white to color, two-dimensional to three-dimensional, and, most recently, four-dimensional. This coincides with the rise of 3D printing, which can convert these medical imaging data sets from virtual to actual models. Countless engineers are continuously looking for more sophisticated imaging applications for 3D printing technology. The most recent development that is gaining international interest is the ability to create 3D-printed substitute tissues and organs from living tissue. A few firms and institutes have already begun to investigate these possibilities, and they are known as bio-printers. EnvisionTEC Inc., a German corporation, has created a bio-printer known as the "3D bio-plotter system." This machine makes scaffolds out of a variety of materials, including soft hydrogels, polymer melts, and hard ceramics and metals. Organovo Holdings Inc. uses another bio-printer and has already begun selling 3D-printed liver cells as well as kidney and skin tissues. Major Key Players in the 3D Medical Imaging Market are identified through secondary research and their market revenues are determined through primary and secondary research. Secondary research included a review of annual and financial reports of leading manufacturers, while primary research included interviews with important opinion leaders and industry experts such as skilled front-line personnel, entrepreneurs, and marketing professionals. Some of the leading key players in the global 3D Medical Imaging Market include GE Healthcare, Philips Healthcare, Analogic, and ContextVision. They are continuously strategizing on mergers and acquisitions, strategic alliances, joint ventures, and partnerships for the growth of their market shares.To know about the Research Methodology :- Request Free Sample Report Medical imaging is required for the exact identification of particular info concerning the physiology of the patient. CT and MRI data may be analyzed using medical imaging to provide prototypes for patient-specific implant fabrication. CT scan data, for example, can be used to acquire parameters of an implant targeted for the injured region of the eye. The implant created using fast prototyping technology can then be effectively implanted to the injured location in the next phase. In the case of fresh organ transplantation, three-dimensional arterial structure models may also be produced using medical photographs. Surgical teams gain greatly from additive manufacturing technology for demonstrating and deciding surgical approaches. A three-dimensional model, on the other hand, provides more information for permitting multiple surgical methods. Anatomic models can also be used to communicate disease and surgical risks to patients.
3D Medical Imaging Market Dynamics:
• The primary driver of the market is a growing elderly population and an increase in the frequency of related disorders. The chance of getting illnesses rises in direct proportion to age. According to the Centers for Disease Control and Prevention, approximately 79% of older people in the United States have at least one chronic illness. Furthermore, the American Medical Association predicts that by 2030, at least 65% of people aged 60 and up would have more than one long-term illness. As the population ages, there will be greater demand for better medical facilities, as well as enhanced treatment choices and drugs. The predominance of age-related disorders e.g. Alzheimer's disease, Parkinson's disease, and dementia, as well as cardiovascular diseases and cancer, is estimated to increase as the global elderly population grows. • A major restraint of the market is technology constraints related with self - contained systems. The technological restrictions of independent imaging methods discourage scientists from acquiring them, limiting their market growth. For example, MRI requires more time to scan big volumes or provide high-quality pictures, but PET has a lesser pixel density. Ultrasound systems are highly reliant on the technician, necessitate direct touch with the person, and have minimal tissue depth penetration. SPECT (Single-photon emission computed tomography) has limited detection capability, whereas CT has a weak soft-tissue distinction, offering less insight on functional qualities and exposing both clinicians and patients to radioactivity. • A major challenge in the market is the lack of adequate healthcare funding for hospitals. In response to increased regulatory pressure to reduce medical costs, a number of healthcare institutions have partnered with Group Buying Organizations, Integrated Health Groups, and Integrated Delivery Networks. These groups pool their members' spending power and negotiate a competitive rate with medical device producers. For large procurement of diagnostic imaging devices, these organizations bargain fiercely. The growing cost of prescribed pharmaceuticals, combined with a steep decrease in anticipated funds allocated for Health & Human Services in the United States for 2021, have resulted in major cuts to hospital budgets. According to an American Hospital Association report, federal hospital payment decreases totalling USD 220 billion by 2029, requiring hospitals to spend lesser resources.3D Medical Imaging Market Segment Analysis:
By Application, the cardiology segment is expected to grow at the fastest rate of 3.2% in the previously mentioned forecast period. This rapid growth rate can be attributed to the ongoing developments in 3-dimensional echocardiography technology. Continuous advancements in 3-dimensional (3D) echocardiography innovation continue to broaden the scope of this imaging paradigm in therapeutic cardiology by introducing additional characteristics derived from the capacity to view the heart as its whole. Numerous papers have documented these benefits and explored new areas where 3D echocardiographic imaging appeared to provide potential approaches to improve patients' treatment throughout the years. Improved chamber measurement techniques and innovative means to observe heart valves, such as 3D printing, VR technology, and holography, are among them.The cardiac intervention has progressed significantly in terms of coronary intervention but intracardiac procedures have been hampered by lack of a live, high-resolution three-dimensional (3D) imaging modality. The creation of equipment to operate within a beating heart and the improvement of imaging techniques that allow trustworthy treatments to be conducted are two of the key difficulties that practitioners face. For the clinical evaluation of coronary architecture and the implantation of surgical stents, X-ray fluoroscopy has been the basis of interventional cardiology. Electro physiologists have adopted x-ray methods in parallel, but movement within a heart chamber is difficult since devices move in three dimensions when not constrained to an artery. To address this issue, tracking devices, many of which involve electromagnetic sensors, have been created to generate virtual heart chambers that provide the surgeon, with a 3D image.
3D Medical Imaging Market Regional Insights:
Emerging economies e.g. India, China, Brazil, South Korea, Turkey, Russia, and South Africa provide significant potential prospects for medical 3D imaging market participants. Although cost is an issue in these emerging nations, their large population bases, particularly in India and China, provide a sustained market for 3D imaging technologies. The increased prevalence of chronic illnesses, e.g. cancer, brain hemorrhage, and cardiovascular or respiratory disorders, as well as the increased mortality in these nations, highlight the need for early diagnosis. According to 2021 data, emerging countries account for about half of the global cancer population.To enhance their presence in this region, the leading market players are implementing a variety of growth tactics. Siemens, for example, said that China is one of their largest markets and the main source of incremental changes. Furthermore, as part of its India development strategy, Siemens launched a production facility in India in 2021 with two production lines one for its Cios Fit brand and the other for CT systems that rely on its Somatom framework. The objective of the report is to present a comprehensive analysis of the 3D Medical Imaging market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the 3D Medical Imaging market dynamics, structure by analyzing the market segments and projecting the 3D Medical Imaging market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the 3D Medical Imaging market make the report investor’s guide.
3D Medical Imaging Market Scope: Inquire before buying
Global 3D Medical Imaging Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 29.65 Bn. Forecast Period 2022 to 2029 CAGR: 6.7 % Market Size in 2029: US $ 49.81 Bn. Segments Covered: by Technology • CT-Scan • MRI • Ultrasound • Neurological Imaging • Spinal Imaging • Other by Deployment • On-premise based platform • Cloud-based platform • Web-based platform by Application • Oncology • Cardiology • Orthopedic • Other by End-User • Hospitals • Ambulatory & healthcare centers • Diagnostic centers • Research centers 3D Medical Imaging Market, by Region
• North America • Europe • Asia Pacific • Middle East and Africa • South America3D Medical Imaging Market Key Players
• GE Healthcare • Hitachi Medical Corp. • Philips Healthcare • Analogic • ContextVision • EOS Imaging • Esaote • Fuel 3D Technologies • FUJIFILM Medical System • Gendex • Hologic • Imaging Sciences International • Intelerad Medical System • Intrasense • Mindray Medical International • Mithil Scans • J. Morita • Planmeca FAQs: 1. Which is the potential market for 3D Medical Imaging in terms of the region? Ans. Emerging economies e.g. India, China, Brazil, South Korea, Turkey, Russia, and South Africa provide significant potential prospects for medical 3D imaging market participants. 2. What are the challenges for new market entrants? Ans. A major challenge in the market is the lack of adequate healthcare funding for hospitals. 3. What is expected to drive the growth of the 3D Medical Imaging market in the forecast period? Ans. The primary driver of the market is a growing elderly population and an increase in the frequency of related disorders. 4. What is the projected market size & growth rate of the 3D Medical Imaging Market? Ans. 3D Medical Imaging Market size was valued at US$ 29.65 Bn. in 2021 and the total 3D Medical Imaging revenue is expected to grow at 6.7% through 2022 to 2029, reaching nearly US$ 49.81 Bn. 5. What segments are covered in the 3D Medical Imaging Market report? Ans. The segments covered are Technology, Deployment, Application, End-Users, and Region.
1. Global 3D Medical Imaging Market: Research Methodology 2. Global 3D Medical Imaging Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global 3D Medical Imaging Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global 3D Medical Imaging Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global 3D Medical Imaging Market Segmentation 4.1 Global 3D Medical Imaging Market, by Technology (2021-2029) • CT-Scan • MRI • Ultrasound • Neurological Imaging • Spinal Imaging • Other 4.2 Global 3D Medical Imaging Market, by Application (2021-2029) • Oncology • Cardiology • Orthopedic • Other 4.3 Global 3D Medical Imaging Market, by Deployment (2021-2029) • On-premise based platform • Cloud-based platform • Web-based platform 4.4 Global 3D Medical Imaging Market, by End-users (2021-2029) • Hospitals • Ambulatory & healthcare centers • Diagnostic centers • Research centers 5. North America 3D Medical Imaging Market(2021-2029) 5.1 Global 3D Medical Imaging Market, by Technology (2021-2029) • CT-Scan • MRI • Ultrasound • Neurological Imaging • Spinal Imaging • Other 5.2 Global 3D Medical Imaging Market, by Application (2021-2029) • Oncology • Cardiology • Orthopedic • Other 5.3 Global 3D Medical Imaging Market, by Deployment (2021-2029) • On-premise based platform • Cloud-based platform • Web-based platform 5.4 Global 3D Medical Imaging Market, by End-users (2021-2029) • Hospitals • Ambulatory & healthcare centers • Diagnostic centers • Research centers 5.5 North America 3D Medical Imaging Market, by Country (2021-2029) • United States • Canada • Mexico 6. Europe 3D Medical Imaging Market (2021-2029) 6.1. European 3D Medical Imaging Market, by Technology (2021-2029) 6.2. European 3D Medical Imaging Market, by Application (2021-2029) 6.3. European 3D Medical Imaging Market, by Deployment (2021-2029) 6.4. European 3D Medical Imaging Market, by End-users (2021-2029) 6.5. European 3D Medical Imaging Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific 3D Medical Imaging Market (2021-2029) 7.1. Asia Pacific 3D Medical Imaging Market, by Technology (2021-2029) 7.2. Asia Pacific 3D Medical Imaging Market, by Application (2021-2029) 7.3. Asia Pacific 3D Medical Imaging Market, by Deployment (2021-2029) 7.4. Asia Pacific 3D Medical Imaging Market, by End-users (2021-2029) 7.5. Asia Pacific 3D Medical Imaging Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa 3D Medical Imaging Market (2021-2029) 8.1 Middle East and Africa 3D Medical Imaging Market, by Technology (2021-2029) 8.2. Middle East and Africa 3D Medical Imaging Market, by Application (2021-2029) 8.3. Middle East and Africa 3D Medical Imaging Market, by Deployment (2021-2029) 8.4. Middle East and Africa 3D Medical Imaging Market, by End-users (2021-2029) 8.5. Middle East and Africa 3D Medical Imaging Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America 3D Medical Imaging Market (2021-2029) 9.1. South America 3D Medical Imaging Market, by Technology (2021-2029) 9.2. South America 3D Medical Imaging Market, by Application (2021-2029) 9.3. South America 3D Medical Imaging Market, by Deployment (2021-2029) 9.4. South America 3D Medical Imaging Market, by End-users (2021-2029) 9.5. South America 3D Medical Imaging Market, by Country (2021-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 GE Healthcare 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Hitachi Medical Corp. 10.3 Philips Healthcare 10.4 Analogic 10.5 ContextVision 10.6 EOS Imaging 10.7 Esaote 10.8 Fuel 3D Technologies 10.9 FUJIFILM Medical System 10.10 Gendex 10.11 Hologic 10.12 Imaging Sciences International 10.13 Intelerad Medical System 10.14 Intrasense 10.15 Mindray Medical International 10.16 Mithil Scans 10.17 J. Morita 10.18 Planmeca